Showing results (311-320 of 996) with videos related to
Sort By:
Pageof 100
Journal of Surgical Oncology|May 7, 2021
Peritoneal cytology as an indicator of peritoneal metastases in colorectal cancerPaul H Sugarbaker, Tom Deng, David ChangGynecologic Oncology Reports|March 22, 2021
Long-term outcomes after cytoreductive surgery and HIPEC for morcellated uterine leiomyosarcoma; A case seriesMaya Yasukawa, Louis A Dainty, Paul H SugarbakerJournal of Surgical Oncology|August 30, 2008
Treatment failure following complete cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal dissemination from colorectal or appendiceal mucinous neoplasmsLana Bijelic, Tristan D Yan, Paul H SugarbakerCancer Treatment and Research|February 28, 2001
Malignant pleural mesotheliomaL Ho, D J Sugarbaker, A T SkarinCancer Treatment and Research|January 1, 1996
Clinical determinants of treatment failure in patients with pseudomyxoma peritoneiP H Sugarbaker, V Fernández-Trigo, F ShamsaThe Journal of Surgical Research|August 29, 2003
Pharmacokinetics and tissue distribution of intraperitoneal docetaxel with different carrier solutionsFaheez Mohamed, O Anthony Stuart, Paul H SugarbakerTransplantation|January 1, 1984
Effects of passive enhancement on graft and host. Graft adaptation by alloantibody as the mechanism of prolonged skin allograft survivalC S McCullough, P H Sugarbaker, W MatthewsPleura and Peritoneum|March 27, 2019
Overview of the optimal perioperative intraperitoneal chemotherapy regimens used in current clinical practiceKurt Van der Speeten, Lieselotte Lemoine, Paul SugarbakerSeminars in Thoracic and Cardiovascular Surgery|October 14, 2009
Surgical techniques for multimodality treatment of malignant pleural mesothelioma: extrapleural pneumonectomy and pleurectomy/decorticationAndrea S Wolf, Jonathan Daniel, David J SugarbakerCytometry|January 1, 1990
Detection of cells resistant to alkylating agents by flow cytometric analysis of DNA damageO S Frankfurt, D Seckinger, E V SugarbakerPageof 100